Annelien L. Bredenoord

Author

Also Known As

A Bredenoord, A L Bredenoord, A. L. Bredenoord, A.L. Bredenoord, Annelien BREDENOORD, Annelien Bredenoord, Annelien L Bredenoord, Annelien L. BREDENOORD, Annelien L. Bredenoord, Annelien L. Bredenoord

216

Publications

6.1K

Citations

H-Index

180

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Cal Humanities Maastricht University The Netherlands Cancer Institute

About

Annelien L. Bredenoord is an author at University Medical Center Utrecht specializing in medicine, public health, and research ethics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	8	8	461
2	Health Sciences	4	4	220
3	Education	3	3	94
4	Law	3	3	296
5	Arts	1	1	11

Annelien L. Bredenoord

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser, The Lancet Neurology Prognostic AssessmentNeurodegenerative DiseasesPersonalised Prediction ModelAmyotrophic Lateral SclerosisDisease Progression	2018	492
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines George Q. Daley, Insoo Hyun, Jane F. Apperley, Stem Cell Reports	2016	219
LifeTime and improving European healthcare through cell-based interceptive medicine Nikolaus Rajewsky, Geneviève Almouzni, Stanislaw A. Gorski, Nature Translational MedicineEuropean HealthcareCell TherapyClinical TranslationImmunology	2020	169
Big Data in medical research and EU data protection law: challenges to the consent or anonymise approach Menno Mostert, Annelien L. Bredenoord, Monique C I H Biesaart, European Journal of Human Genetics EngineeringLawResearch EthicsHealth LawData Science	2015	145
CRISPR germline engineering—the community speaks Katrine Bosley, Michael Botchan, Annelien L. Bredenoord, Nature Biotechnology EngineeringGenome SurgeryGeneticsBiotechnologyGenetic Engineering	2015	140
From deficit to dialogue in science communication Cathelijne M. Reincke, Annelien L. Bredenoord, Marc H. W. van Mil EMBO Reports	2020	137
Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy Annelien L. Bredenoord, N. Charlotte Onland‐Moret, Johannes J. M. van Delden Human Mutation Family MedicineGenetic TestingResearch ParticipantsHealth PolicyBiobank	2011	126
Debate ethics of embryo models from stem cells Nicolas Rivron, Martín F. Pera, Janet Rossant, Nature Embryonic Stem CellDevelopmental BiologyBiomedical EthicMedicineStem Cell Research	2018	125
Should the 14‐day rule for embryo research become the 28‐day rule? John Appleby, Annelien L. Bredenoord EMBO Molecular Medicine	2018	105
Organoids as hybrids: ethical implications for the exchange of human tissues Sarah N. Boers, Johannes J. M. van Delden, Annelien L. Bredenoord Journal of Medical Ethics	2018	89

Page 1